The Enterprise Value as of December 2024 (TTM) for CRISPR Therapeutics AG (CRSP) is 3.46B

According to CRISPR Therapeutics AG’s latest financial reports and current stock price. The company's current Enterprise Value is 3.46B. This represents a change of -24.34% compared to the average of 4.57B of the last 4 quarters.

CRISPR Therapeutics AG (CRSP) Historical Enterprise Value (quarterly & annually)

How has CRSP Enterprise Value performed in the past?

The mean historical Enterprise Value of CRISPR Therapeutics AG over the last ten years is 2.67B. The current 3.46B Enterprise Value has changed 12.84% with respect to the historical average. Over the past ten years (40 quarters), CRSP's Enterprise Value was at its highest in in the June 2021 quarter at 10.82B. The Enterprise Value was at its lowest in in the March 2015 quarter at 0.

CRISPR Therapeutics AG (CRSP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CRISPR Therapeutics AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CRISPR Therapeutics AG (CRSP) Average Enterprise Value

How has CRSP Enterprise Value performed in the past?

The current Enterprise Value of CRISPR Therapeutics AG (CRSP) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

CRISPR Therapeutics AG (CRSP) Enterprise Value vs. Peers

How is CRSP’s Enterprise Value compared to its peers?

CRISPR Therapeutics AG’s Enterprise Value is greater than Beam Therapeutics Inc. (2.31B), greater than Editas Medicine, Inc. (45.84M), greater than Caribou Biosciences, Inc. (156.76M), greater than Verve Therapeutics, Inc. (412.06M), greater than Intellia Therapeutics, Inc. (1.21B), greater than Fate Therapeutics, Inc. (250.13M), less than Regeneron Pharmaceuticals, Inc. (77.98B), less than Novo Nordisk A/S (2.61T), less than Sarepta Therapeutics, Inc. (12.73B), greater than CohBar, Inc. (-4359535.00), greater than Hepion Pharmaceuticals, Inc. (4.20M), greater than Rain Therapeutics Inc. (7.16M), less than Krystal Biotech, Inc. (4.25B), greater than AVROBIO, Inc. (-85302404.00),

Build a custom stock screener for CRISPR Therapeutics AG (CRSP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CRISPR Therapeutics AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CRISPR Therapeutics AG (CRSP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CRISPR Therapeutics AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.